CMS/FDA Parallel Review: Agencies Weighing Process For Planning Trials That Satisfy Both

CMS and FDA are considering a voluntary process that would help drug, biologic and medical device sponsors design clinical trials that would ultimately support both FDA approval and CMS national coverage decisions for Medicare reimbursement.